Regina Jehle - Abivax SA VP Communications
| ABVX Stock | EUR 7.66 0.19 2.42% |
Insider
Regina Jehle is VP Communications of Abivax SA
| Phone | 33 1 53 83 08 41 |
| Web | https://www.abivax.com |
Abivax SA Management Efficiency
The company has return on total asset (ROA) of (0.4368) % which means that it has lost $0.4368 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (12.8647) %, meaning that it generated substantial loss on money invested by shareholders. Abivax SA's management efficiency ratios could be used to measure how well Abivax SA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | INSIDER Age | ||
| Philippe Rousseau | Biophytis SA | 52 | |
| Thomas Iff | Eurobio Scientific SA | N/A | |
| Herve MBA | Eurobio Scientific SA | 64 | |
| Benoit Canolle | Biophytis SA | 45 | |
| Jacques Martin | Eurobio Scientific SA | N/A | |
| Denis Fortier | Eurobio Scientific SA | 55 | |
| JeanMichel Grandmougin | Eurobio Scientific SA | 62 | |
| Teylan | Biophytis SA | N/A | |
| FFPM MBA | Biophytis SA | 52 | |
Management Performance
| Return On Equity | -12.86 | |||
| Return On Asset | -0.44 |
Abivax SA Leadership Team
Elected by the shareholders, the Abivax SA's board of directors comprises two types of representatives: Abivax SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abivax. The board's role is to monitor Abivax SA's management team and ensure that shareholders' interests are well served. Abivax SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abivax SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Didier Blondel, CFO, Board Secretary | ||
| Alain Chevallier, Advisor | ||
| Philippe MD, Founder Director | ||
| Regina Jehle, VP Communications | ||
| Prof Ehrlich, Chief Officer | ||
| Paul Gineste, VP Operations | ||
| Anne Pascard, HR Mang | ||
| Raquel Lizarraga, Investor Mang | ||
| Pierre MBA, Chief Devel | ||
| Alexandra Pearce, Vice President and Head of Regulatory Affairs |
Abivax Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Abivax SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -12.86 | |||
| Return On Asset | -0.44 | |||
| Operating Margin | 4.66 % | |||
| Current Valuation | 157.22 M | |||
| Shares Outstanding | 42.32 M | |||
| Shares Owned By Insiders | 2.46 % | |||
| Shares Owned By Institutions | 30.18 % | |||
| Price To Earning | (7.59) X | |||
| Price To Book | 22.19 X | |||
| Price To Sales | 3,840 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Abivax Stock
Abivax SA financial ratios help investors to determine whether Abivax Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abivax with respect to the benefits of owning Abivax SA security.